← Evidence map

ArticleCancers2026

Integrative Proteomics and Machine Learning Identify SLC27A2 as a Candidate Biomarker and Potential Mediator of Pyrotinib Response in HER2-Positive Breast Cancer.

Shiyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Integrative Proteomics and Machine Learning Identify SLC27A2 as a Candidate Biomarker and Potential Mediator of Pyrotinib Response in HER2-Positive Breast Cancer. | OpenQuestion